DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TRASTUZUMAB-ANNS
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-ANNS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROUS FUMARATE
4
Small molecule
Approved
OTHER
ORAL
Helicobacter Infections; HIV Infections; Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency
Supplement
FERROUS FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
R5L488RY0Q
Molecule Type:
Small molecule
Molecular Formula:
C4H2FeO4
Molecular Weight:
169.9
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BESIFOVIR DIPIVOXIL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BESIFOVIR DIPIVOXIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAGNESIUM ASPARTATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MAGNESIUM ASPARTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
R17X820ROL
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIETHYLTOLUAMIDE
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
DIETHYLTOLUAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
FB0C1XZV4Y
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO
Molecular Weight:
191.27
AlogP:
2.48
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ARGIPRESSIN TANNATE
4
Protein
Approved
Unknown
Unknown
Unknown
Vasopressin receptor agonist
ARGIPRESSIN TANNATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXAMETHASONE-21-SULFOBENZOATE, SODIUM SALT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
DEXAMETHASONE-21-SULFOBENZOATE, SODIUM SALT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPOETIN THETA
4
Protein
Approved
Unknown
Unknown
Unknown
Erythropoietin receptor agonist
EPOETIN THETA
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M SESTAMIBI KIT
4
Small molecule
Approved
OTHER; PREGNANCY AND GYNECOLOGY
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M SESTAMIBI KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; METHOCARBAMOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; METHOCARBAMOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALMITRINE MESYLATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ALMITRINE MESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6RY6V6XM8T
Molecule Type:
Small molecule
Molecular Formula:
C28H37F2N7O6S2
Molecular Weight:
669.78
AlogP:
4.26
PSA:
69.21
HBD:
2.0
HBA:
#RotB:
10.0
Source:
HUMAN COAGULATION FACTOR IX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HUMAN COAGULATION FACTOR IX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISMUTH SUBCITRATE
4
Small molecule
Unknown
Unknown
Unknown
Lymphoma
Unknown
BISMUTH SUBCITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
HS813P8QPX
Molecule Type:
Small molecule
Molecular Formula:
C12H13BiO14
Molecular Weight:
590.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OCTOXYNOL 9
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
OCTOXYNOL 9
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H50O8
Molecular Weight:
514.7
AlogP:
3.87
PSA:
84.84
HBD:
1.0
HBA:
#RotB:
23.0
Source:
METAMIZOLE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
METAMIZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUTRIMAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUTRIMAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
776S0UP252
Molecule Type:
Small molecule
Molecular Formula:
C22H16F2N2
Molecular Weight:
346.38
AlogP:
5.0
PSA:
17.82
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MOXISYLYTE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases; Erectile Dysfunction
Adrenergic receptor alpha antagonist
MOXISYLYTE
×
Maximum Phase:
4
First Approval:
None
UNII:
PW8QYA7KI0
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO3
Molecular Weight:
279.38
AlogP:
2.98
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
CLEBOPRIDE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Dopamine D2 receptor antagonist
CLEBOPRIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
I0A84520Y9
Molecule Type:
Small molecule
Molecular Formula:
C20H24ClN3O2
Molecular Weight:
373.88
AlogP:
3.33
PSA:
67.59
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALCOHOL; DEXTROSE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ALCOHOL; DEXTROSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYTARABINE; DAUNORUBICIN
4
Combination
Approved
Unknown
INTRAVENOUS
Unknown
Unknown
CYTARABINE; DAUNORUBICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUORODEOXYPHENYLALANINE
4
Unknown
Approved
Unknown
INJECTION
Unknown
Unknown
FLUORODEOXYPHENYLALANINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPERAZINE
4
Small molecule
Approved
Unknown
Unknown
Helminthiasis
Unknown
PIPERAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
1RTM4PAL0V
Molecule Type:
Small molecule
Molecular Formula:
C4H10N2
Molecular Weight:
86.14
AlogP:
-0.82
PSA:
24.06
HBD:
2.0
HBA:
#RotB:
0.0
Source:
HYDROCHLOROTHIAZIDE; LISINOPRIL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; LISINOPRIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBICISTAT; DARUNAVIR ETHANOLATE; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
COBICISTAT; DARUNAVIR ETHANOLATE; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUAR GUM
4
Unknown
Approved
Unknown
Unknown
Parkinson Disease; Diabetes Mellitus
Unknown
GUAR GUM
×
Maximum Phase:
4
First Approval:
None
UNII:
E89I1637KE
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUCLORONIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUCLORONIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
MG258KTA37
Molecule Type:
Small molecule
Molecular Formula:
C24H29Cl2FO5
Molecular Weight:
487.4
AlogP:
3.88
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
257
258
259
260
261
262
263
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA